| Stage | NOV | % of rev | UHS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $4.6B | 100.00% | UHS ×2.08 |
| Gross profit | $439M | 19.72% | $2.5B | 53.85% | UHS +34.1pp |
| Operating income | $142M | 6.38% | $517M | 11.14% | UHS +4.8pp |
| Pre-tax income | $123M | 5.53% | $479M | 10.33% | UHS +4.8pp |
| Net income | $95M | 4.27% | $365M | 7.86% | UHS +3.6pp |
| Stage | NOV | UHS | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $4.6B100.00% | UHS ×2.08 |
| Gross profit | 19.72%$439M | 53.85%$2.5B | UHS +34.1pp |
| Operating income | 6.38%$142M | 11.14%$517M | UHS +4.8pp |
| Pre-tax income | 5.53%$123M | 10.33%$479M | UHS +4.8pp |
| Net income |
| 4.27%$95M |
| 7.86%$365M |
| UHS +3.6pp |